Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry

Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry

Abstract Background Data on fibrinolytic therapy use for ST-segment elevation myocardial infarction (STEMI) and long-term clinical outcomes in developing countries are limited. We aimed to investigate the management and 2-year mortality of fibrinolytic-treated patients in China. Methods A total of 1...

Full description

Bibliographic Details
Main Authors: Chao Wu, Ling Li, Shuqing Wang, Jianping Zeng, Jingang Yang, Haiyan Xu, Yanyan Zhao, Yang Wang, Wei Li, Chen Jin, Xiaojin Gao, Yuejin Yang, Shubin Qiao
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Cardiovascular Disorders
Subjects:
ST-segment elevation myocardial infarction
Fibrinolysis
Outcomes
Online Access:https://doi.org/10.1186/s12872-023-03105-1

Internet

https://doi.org/10.1186/s12872-023-03105-1

Similar Items